AllianceBernstein’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.28M | Hold |
31,120
| – | – | ﹤0.01% | 1544 |
|
2025
Q1 | $5.61M | Hold |
31,120
| – | – | ﹤0.01% | 1410 |
|
2024
Q4 | $4.88M | Buy |
31,120
+1,400
| +5% | +$219K | ﹤0.01% | 1499 |
|
2024
Q3 | $5.41M | Hold |
29,720
| – | – | ﹤0.01% | 1488 |
|
2024
Q2 | $5.46M | Buy |
29,720
+5,960
| +25% | +$1.09M | ﹤0.01% | 1456 |
|
2024
Q1 | $4.23M | Sell |
23,760
-2,140
| -8% | -$381K | ﹤0.01% | 1529 |
|
2023
Q4 | $3.21M | Hold |
25,900
| – | – | ﹤0.01% | 1696 |
|
2023
Q3 | $3M | Sell |
25,900
-200
| -0.8% | -$23.2K | ﹤0.01% | 1652 |
|
2023
Q2 | $3.06M | Hold |
26,100
| – | – | ﹤0.01% | 1663 |
|
2023
Q1 | $2.09M | Hold |
26,100
| – | – | ﹤0.01% | 1845 |
|
2022
Q4 | $2.07M | Buy |
26,100
+600
| +2% | +$47.5K | ﹤0.01% | 1900 |
|
2022
Q3 | $1.78M | Hold |
25,500
| – | – | ﹤0.01% | 1955 |
|
2022
Q2 | $1.67M | Buy |
25,500
+2,100
| +9% | +$138K | ﹤0.01% | 2051 |
|
2022
Q1 | $1.56M | Buy |
23,400
+2,700
| +13% | +$180K | ﹤0.01% | 2220 |
|
2021
Q4 | $1.45M | Hold |
20,700
| – | – | ﹤0.01% | 2312 |
|
2021
Q3 | $1.08M | Hold |
20,700
| – | – | ﹤0.01% | 2455 |
|
2021
Q2 | $1.41M | Buy |
20,700
+7,100
| +52% | +$483K | ﹤0.01% | 2368 |
|
2021
Q1 | $1.05M | Buy |
13,600
+300
| +2% | +$23.1K | ﹤0.01% | 2381 |
|
2020
Q4 | $798K | Hold |
13,300
| – | – | ﹤0.01% | 2389 |
|
2020
Q3 | $573K | Sell |
13,300
-700
| -5% | -$30.2K | ﹤0.01% | 2457 |
|
2020
Q2 | $580K | Buy |
14,000
+2,600
| +23% | +$108K | ﹤0.01% | 2498 |
|
2020
Q1 | $493K | Sell |
11,400
-600
| -5% | -$25.9K | ﹤0.01% | 2356 |
|
2019
Q4 | $665K | Buy |
12,000
+2,700
| +29% | +$150K | ﹤0.01% | 2423 |
|
2019
Q3 | $323K | Buy |
9,300
+1,200
| +15% | +$41.7K | ﹤0.01% | 2766 |
|
2019
Q2 | $326K | Buy |
+8,100
| New | +$326K | ﹤0.01% | 2790 |
|